ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $13,000 | -78.3% | 326 | -68.9% | 0.00% | -100.0% |
| Q2 2015 | $60,000 | -10.4% | 1,047 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $67,000 | +570.0% | 1,047 | +562.7% | 0.00% | – |
| Q4 2014 | $10,000 | -92.6% | 158 | -95.5% | 0.00% | -100.0% |
| Q3 2014 | $136,000 | +81.3% | 3,501 | +61.3% | 0.00% | 0.0% |
| Q2 2014 | $75,000 | -39.5% | 2,170 | -24.3% | 0.00% | 0.0% |
| Q1 2014 | $124,000 | +2380.0% | 2,867 | +2023.7% | 0.00% | – |
| Q4 2013 | $5,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |